You are here: Industry Insights > ovarian

News List

Farrer Park Hospital Collaborates with Sincere Healthcare Group & Icon Cancer Centre Singapore to Introduce Fertility Preservation Services for Cancer Patients prnasia
June 22, 2021
Farrer Park Hospital today announced its collaboration with Sincere Healthcare Group (SHG) and Icon Cancer Centre Singapore (ICCS) to provide fertility preservation services for reproductive-age female cancer patients.
Oral contraceptive pills protect against ovarian and endometrial cancer, study finds europeanpharmaceuticalreview
December 22, 2020
A study has shown that the use of oral contraceptives gave women a much lower risk of developing both ovarian and endometrial cancer.
NICE approves new tablet formulation for olaparib drug europeanpharmaceuticalreview
December 10, 2019
The UK NICE has extended its approval for olaparib, updating its formulation from eight capsules twice a day to two tablets twice daily.
PTSD a Risk Factor for Ovarian Cancer? drugs
September 06, 2019
Struggling with post-traumatic stress disorder (PTSD) may make a woman more vulnerable to ovarian cancer, a new study suggests.
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer worldpharmanews
August 16, 2019
AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer.
Premature Ovarian Insufficiency Tied to Poor Sleep Quality drugs
August 06, 2019
Women with premature ovarian insufficiency (POI) receiving hormone therapy have poor sleep quality, according to a study published online in Menopause.
Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric drugs
July 11, 2019
Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric.
New study showing drug prolongs life for patients with ovarian cancer worldpharmanews
July 05, 2019
New study showing drug prolongs life for patients with ovarian cancer.
Lynparza has been approved for BRCA-mutated advanced ovarian cancer europeanpharmaceuticalreview
June 24, 2019
BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
Ponatinib is found to be effective against SCCOHT europeanpharmaceuticalreview
April 28, 2019
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months…

Previous page 1 2 Next page